D elays are important markers of quality of care in primary percutaneous coronary intervention (PPCI). Door-to-balloon time has been related to mortality, and its relation seems to be strongest in the early hours of symptom onset. [1] [2] [3] [4] [5] [6] [7] [8] In this regards, recent American College of Cardiology/American Heart Association guidelines determine door-to-balloon time goal of <90 minutes for at least 75% of patients admitted initially to a hospital with PPCI capacity and <120 minutes for at least 90% of transferred patients. 9 Many strategies have been successfully applied to shorten door-to-balloon time before catheterization laboratory arrival but few have been studied to reduce delays inherent to the procedure. 10-17 Hereof, there is scarce data on the impact of obtaining a complete diagnostic angiography before PPCI. Our study sought to determine whether a strategy of performing culprit-vessel revascularization before obtaining contralateral or complete diagnostic angiography could be associated with a reduction in delays and outcomes in ST-segment-elevation myocardial infarction (STEMI) patients. ) is a tertiary care center that maintains an ongoing prospective clinical registry of all STEMI patients undergoing cardiac catheterizations as already described in a previous study. 18 After providing written informed consent, patients were enrolled into this registry. Clinical and procedural characteristics as well as important time points were entered in a database. At the time of the intervention, delays were obtained from nurses, paramedics, and physicians' notes. Time for (1) first medical contact, (2) diagnostic Background-Delays are important markers of quality of care in primary percutaneous coronary intervention. There is scarce data on the impact of obtaining a complete diagnostic angiography before primary percutaneous coronary intervention.
Culprit First Revascularization to Reduce Delays ECG, (3) door-in and door-out from referring hospital, (4) door-in at our institution, (5) arrival of patient in the catheterization laboratory, (6) obtaining vascular access, and (7) first coronary intervention in the culprit artery were all prospectively collected. First medical contact-to-balloon time (FMBT) delay was calculated from first medical contact to first coronary intervention with thrombectomy, balloon angioplasty, or direct stenting. Vascular access-toballoon time (VABT) was calculated from time of vascular access to intervention.
Vital status at 30 days was confirmed for every patient through the hospital's computerized database or phone calls made by either our research or laboratory staff. Medical charts were reviewed to capture ischemic and bleeding events.
Study Cohort
This is a single-center, retrospective study of all consecutive STEMI patients treated with PPCI at our institution between January 2012 and December 2014. Inclusion criterion was STEMIs treated with PPCI. Patients who received fibrinolytic therapy and patients who were treated medically or referred for coronary artery bypass surgery (CABG) after coronary angiography were excluded. Patients with previous CABG were excluded from the study.
All cine-angiography were reviewed by a single investigator (E.L. Couture). Patients were categorized into 3 groups according to the strategy used by the operator. Group 1 patients were treated with culprit vessel ECG-guided percutaneous coronary intervention (PCI) before undergoing a complete diagnostic coronary angiogram. Group 2 consisted of patients for whom the operator chose to perform coronary angiography of the culprit vessel with a guiding catheter after imaging the contralateral coronary artery. Group 3 patients underwent complete coronary angiography first with diagnostics catheters, followed by PCI. When PCI was done after a contralateral angiogram performed with a guiding catheter on a nonculprit vessel, the patient was included in group 2. Hence, group differentiation was based on an as-treated strategy. Culprit coronary artery was defined as any vessel with an acute thrombotic total or subtotal occlusion. The choice of the procedural strategy was left at the discretion of the operator.
Outcomes
The primary outcome of this study was VABT. Secondary outcomes included FMBT, mortality and repeat myocardial infarction at 30 days, CABG referral <3 months, and in-hospital bleeding events (bleeding academic research consortium definition for bleeding ≥3 type).
Statistical Analysis
Data are expressed as counts and percentages for categorical variables and as mean±SD or median (interquartile range) for continuous variables. Statistical comparisons were performed using χ 2 tests for categorical and binary data. Analysis of variance and Kruskal-Wallis test were used for normally and non-normally distributed continuous data, respectively. Test for an ordered alternative hypothesis within an independent sample was performed with the Jonckheere trend test.
Multivariable logistic regression models were used to identify independent predictors of PPCI via a culprit-vessel first strategy. Candidate variables of interest included demographics, comorbidities, cardiac history, and admission characteristics, as shown in Table 1 . The contribution of each variable to the overall model was determined using odds ratios. A propensity score-matched cohort was created to minimize the influence of potential confounders and selection bias by matching each patient in culprit-vessel revascularization first group with a patient in the contralateral and another in the complete angiography first group using a 3-way 1:1:1 nearest-neighbor matching. For this match, we set the caliper to be 0.6× ((τ 2 +τ 2 +τ 2 )/3) ½ , where the τ 2 values were the average of the 2 observed variances for patients' 2 propensity scores, with a τ 2 value for each treatment group. Patients were excluded from the matched cohort if they failed to achieve a distance shorter than the caliper for a given matched trio. This matching method has been previously described and validated by Rassen et al. 19 All baseline covariates that were associated with treatment assignment (P value <0.2) were include in the propensity score model. The balance between the 3 matched groups was determined by computing P value for each explanatory factor.
Treatment times and clinical outcomes were compared before and after propensity score matching.
Analysis was done using SPSS 23.0 (IBM, Armonk, NY). Threeway 1:1:1 matching was computed using SAS 9.2 (SAS Institute, Inc, Cary, NC). A P value <0.05 was considered to indicate statistical significance. The study was approved by the local research ethics board.
Results
A total of 949 patients with STEMI were screened during the study period. Of these, 925 patients met the inclusion criterion and were included in this analysis. The strategy used was PCI first in 332 patients (36%), contralateral angiography first in 397 patients (43%), and complete angiography first in 196 patients (21%).
The baseline clinical and procedural characteristics for the 3 groups before propensity match are shown in Table 1 . Age, prevalence of diabetes mellitus and hypertension, smoking status, and history of prior PCI were significantly different among the 3 groups before matching. Radial access was used in 73% of all patients, but femoral access was more frequently (63%) used with a complete diagnostic angiography strategy. The multivariable model predictors of culprit-vessel first strategy are shown in Table 2 . Three independent predictors of a culprit-vessel first strategy were identified: (1) absence of diabetes mellitus, (2) radial access, and (3) anterior/lateral infarct location by ECG. The proportion of these 3 strategies used by the 6 operators is shown in Figure 1 . VABT was significantly different between operators (P=0.006; Figure 2 ), with
WHAT IS KNOWN
• Door-to-balloon time is an important marker of quality of care in primary percutaneous coronary intervention and has been related to mortality, especially in the early hours of symptom onset.
• There are scarce data on the safety and utility of performing culprit-vessel primary percutaneous coronary intervention before obtaining a complete angiogram.
WHAT THE STUDY ADDS
• Performing culprit-vessel primary percutaneous coronary intervention before contralateral or complete diagnostic angiography is associated with a small (4-6 minutes) but statistically significant reduction in vascular access-to-balloon time.
• This reduction in time to reperfusion translated in a higher proportion of patients treated within recommended delays.
• Despite improving this quality metric standpoint, culprit revascularization first strategy was not associated with better or worse clinical outcomes.
shorter VABT for those using more frequently a culprit-first strategy (P for trend <0.001). The operator who used preferentially complete diagnostic angiography first was also the only operator using preferentially a femoral approach (in >80%) in comparison to the other 5 operators who used radial access in >80% of cases. When the femoralist operator was excluded from the multivariable model predictors, radial access was not anymore a predictor of revascularization strategy (P=0.67). However, absence of diabetes mellitus and anterior/lateral infarct location by ECG still predicted culprit-vessel first strategy.
After propensity score matching, 180 matched trios were identified. Their baseline characteristics were similar (Table 3 ). Procedural treatment times and clinical outcomes before and after matching are shown in Table 4 . Before matching, culprit-vessel first strategy was associated with shorter median VABT (9 versus 11 versus14 minutes; P<0.001) and shorter median FMBT (99 versus 103 versus 109 minutes; P<0.001) in comparison with contralateral and complete diagnostic angiography first strategies, respectively. No significant differences in clinical outcomes were observed.
After matching, the median VABT was 8 minutes (interquartile range [IQ] [6] [7] [8] [9] [10] [11] [12] ) for the culprit PPCI first group, 12 minutes (IQ [9] [10] [11] [12] [13] [14] [15] ) for the contralateral angiography first group, and 14 minutes (IQ [11] [12] [13] [14] [15] [16] [17] ) for the complete angiography first group (P<0.001 overall and for trend). The median FMBT was 98 minutes (IQ [84-120]) for the culprit PPCI first group, 104 minutes (IQ [90-132]) for the contralateral angiography first group, and 110 minutes (IQ [90-137]) for the complete angiography first group (P=0.002 overall and P=0.001 for trend). The net effect was a median reduction of 4 to 6 minutes favoring culprit PPCI first strategy. Culprit PPCI first increased the proportion of patients treated within FMBT <90 minutes by 9% and 11% in comparison to contralateral angiography first and complete angiography first strategies, respectively (P for trend =0.024; Figure 3 ). When applied to an FMBT of <120 minutes, culprit PPCI first increased the proportion of patients treated within these delays by 7% and 14% (P for trend =0.007). A linear trend in reduction of VABT and FMBT was observed between the 3 strategies (Table 4 ). In these matched patients, no significant difference in 30-day mortality and reinfarction was observed between groups, nor was the rate for CABG referral at 3 months. 
Discussion
Although delay reduction in PPCI is essential, there is scarce data on the safety and efficacy of performing culprit intervention without complete diagnostic angiogram. This propensity-matched analysis revealed that performing culprit PPCI without complete diagnostic angiography significantly shortened delays and improved quality of care measures. However, these reductions in delays were not associated with better clinical outcomes.
In this study, an additional 4 to 6 minutes in VABT was used to complete angiography before PCI and translated into longer FMBT. These small increments in delays were statistically significant but were unlikely to be clinically relevant because clinical end points were similar between groups. However, from a quality metric standpoint, these reductions in reperfusion delays yielded significant higher percentages of patients meeting the FMBT goal <90 and <120 minutes. The magnitude of these changes in proportion of patients achieving those goals could be exaggerated by unknown confounding factors. In fact, the VABT reduction of 4 and 6 minutes translated into an FMTB reduction of 6 and 12 minutes in comparison with contralateral and complete angiography first strategy, respectively. Even after matching, the FMBT reduction was not entirely explained by the VABT reduction. This suggests that there are unmeasured factors happening before initiation of the procedure that have not been accounted for. A reduction of this magnitude is enough to have dramatic improvement in the proportion of patients achieving targeted delays because many patients miss these goals by only a few minutes. In fact, the 90-and 120-minutes time point are located on the steepest part of the FMBT distribution curve (Figure 4) .
In PPCI, the therapeutic goal is clear; it is to restore blow flow to the culprit artery as quickly as possible. It is not surprising that the rate of PCI is high and only rarely emergent CABG is used. 20 Even in patients with triple vessel or left main disease, PCI of the occluded artery should be done promptly, leaving the residual disease to be treated later. CABG after acute coronary syndrome is now frequently performed under dual antiplatelet therapy (using clopidogrel) and not associated with worse outcomes. 21 Performing complete angiography before PCI could (1) avoid treating a nonculprit artery first and (2) influence therapeutics in some patients with restored flow to the culprit artery and multivessel disease. Our descriptive analyses of predictors of culpritvessel first revascularization strategy revealed that absence of diabetes mellitus and anterior/lateral infarct location were the 2 independent factors influencing strategy selection. Diabetes mellitus is linked to multivessel disease, and physicians likely preferred to define complete anatomy before engaging into PCI in that population, especially for those with restored flow. Right coronary anatomy is not likely to influence therapeutic for anterior infarcts, nor is expected to reveal the culprit artery. Hence, most physicians probably felt comfortable to defer right coronary angiography in anterior infarcts. For inferior infarcts, ECG is not as reliable to reveal the culprit artery. A study evaluating delays according to the culprit artery found longer delays for left circumflex artery compared with right coronary and left anterior descending artery. 22 This could be explained by engaging in PCI of a nonculprit right coronary artery while left circumflex artery is the culprit. To avoid this, imaging the contralateral vessel first could be a preferred strategy. There are likely some unknown confounders in our study that favored a strategy over another. Atypical and late presentation, diagnostic uncertainty, and unexplained shock are factors that could influence experienced operators to obtain complete angiography, whereas complete AV block and recurrent ventricular fibrillation in inferior myocardial infarction could lead them to hustle the process of restoring flow to a culprit right coronary artery.
Our finding of a small but statistically significant decrease of 4 to 6 minutes in VABT is consistent with, but remains lowers in magnitude than those previously reported. [13] [14] [15] [16] [17] In a large strictly radial access study, culprit first revascularization reduced door-to-balloon time by a median time of 8 minutes. 14 This study, however, did not report VABT. Smaller studies with femoral access showed larger reduction in VABT of ≤13 minutes. [15] [16] [17] The high number of PPCI performed by our operators (>50 PPCI/y; >250 PCI/y) and our propensity-matched analysis might explain why we observed lower differences in delays than previous studies. The absence of difference in clinical outcomes despite shorter delays is likely explained by the magnitude of delay reduction. A reduction of 5 to 10 minutes is unlikely to translate into better survival, and our observations bed well with other recent publications that failed to show lower mortality despite reduction in door-to-balloon time. [23] [24] [25] [26] The old adage, time is muscle, is an attractive explanation for outcome, but studies correlating total ischemic time to mortality also showed divergent results. [26] [27] [28] [29] Together, these studies tend to demonstrate that delays reduction seems to exert its mortality benefit mostly in STEMI patients treated in the early hours (<4-6 hours) after symptom onset. Prior animal study at the origin of the wavefront phenomenon concept elaboration also pointed out in that direction when they documented the presence of a subepicardial zone of ischemic but viable myocardium which is available for salvage for at least 3 and perhaps 6 hours after circumflex occlusion in dogs. 30 Furthermore, the contribution of radial access to better outcome may bias our interpretation of the relation between delays and outcomes. As Wimmer et al have proposed it in a decision-analytic model, a transradial delay of 83 minutes was needed to offset the 30-day mortality benefit of transradial PPCI. 31 Moreover, after propensity matching, our sample was not powered to detect more than a 30-day mortality difference of 2%.
In light of these results, several limitations need to be acknowledged. Because of the retrospective design, revascularization strategy was not randomized. Although we adjusted for differences in baseline presenting characteristics by using propensity score matching, there may have been residual confounders because of unmeasured patient's variables. For example, multivessel revascularization at the time of PPCI was more frequent in the complete angiography first group. This procedural characteristic might reflect the presence of some unmeasured baseline characteristics that could have influenced the operator's strategy (eg, possibility of multiple culprits based on clinical presentation and ECG). Differences in few procedural characteristics are likely related to differences in operators' preferences because each of them were not equally distributed in each treatment group. However, it is unlikely that these differences have had an impact on our primary issue consisting of reperfusion delays. We did not adjust for the various operators in our analysis because a multivariable regression analysis looking at predictors of shorter VABT revealed that the only predictors of shorter VABT were revascularization strategies (P<0.001). More else, Figures 1 and 2 demonstrated that a shorter mean VABT is associated with operators using more frequently a culprit-first strategy (overall P and P for trend <0.001). Together, these data demonstrated that the VABT is closely associated with strategy selection rather than operator by themselves. Our study did not evaluate reliably the initial intention-to-treat revascularization strategy. Culprit artery localization on initial ECGs is not a perfect science, and this is why we did group differentiation based on the as-treated strategy determined by the angiogram. Follow-up for clinical events was short but probably sufficient to test for the procedurals effects of PPCI, and these data were collected prospectively. However, based on the overall 30-days mortality rate, we estimate that our propensity-matched cohort had the power to detect a 4% mortality difference between groups. A sample of 8151 would be needed to detect a 1% difference.
Conclusions
Based on our observations, it seems safe to perform PPCI without obtaining contralateral angiography first in selected cases, especially anterior infarcts. This strategy is associated with a small reduction in FMBT, and a significant increase in the proportion of patients achieving target delays was observed, although the latter was likely overestimated because of unknown confounders. Obtaining complete angiography first was not associated with better or worse clinical outcomes. Clinical judgment should be used to optimize care in these patients.
